Immunic AG is a dynamic biotechnology company focused on developing innovative therapies for autoimmune diseases and other serious conditions. With a commitment to advancing medical science, Immunic AG emphasizes collaboration and expertise in clinical pharmacology and regulatory writing. The company fosters a remote-friendly work environment, allowing professionals from the EU, UK, and US to contribute to critical projects, particularly in the preparation of New Drug Applications (NDA). Immunic AG values strong project management skills and a proactive approach, ensuring that its team members are well-equipped to navigate the complexities of drug development and regulatory processes.